116 related articles for article (PubMed ID: 35513262)
1. Identification of Two Non-Peptidergic Small Molecule Inhibitors of CBX2 Binding to K27 Trimethylated Oligonucleosomes.
Lercher L; Simon N; Bergmann A; Tauchert M; Bochmann D; Bashir T; Neuefeind T; Riley D; Danna B; Krawczuk P; Pande V; Patrick A; Steele R; Wang W; Rupnow B; Tummino P; Sharma S; Finley M
SLAS Discov; 2022 Jul; 27(5):306-313. PubMed ID: 35513262
[TBL] [Abstract][Full Text] [Related]
2. A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.
Wang S; Alpsoy A; Sood S; Ordonez-Rubiano SC; Dhiman A; Sun Y; Jiao G; Krusemark CJ; Dykhuizen EC
Chembiochem; 2021 Jul; 22(13):2335-2344. PubMed ID: 33950564
[TBL] [Abstract][Full Text] [Related]
3. Nuclear condensates of the Polycomb protein chromobox 2 (CBX2) assemble through phase separation.
Tatavosian R; Kent S; Brown K; Yao T; Duc HN; Huynh TN; Zhen CY; Ma B; Wang H; Ren X
J Biol Chem; 2019 Feb; 294(5):1451-1463. PubMed ID: 30514760
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of CBX2 controls its nucleosome-binding specificity.
Kawaguchi T; Machida S; Kurumizaka H; Tagami H; Nakayama JI
J Biochem; 2017 Nov; 162(5):343-355. PubMed ID: 28992316
[TBL] [Abstract][Full Text] [Related]
5. Cbx2 targets PRC1 to constitutive heterochromatin in mouse zygotes in a parent-of-origin-dependent manner.
Tardat M; Albert M; Kunzmann R; Liu Z; Kaustov L; Thierry R; Duan S; Brykczynska U; Arrowsmith CH; Peters AH
Mol Cell; 2015 Apr; 58(1):157-71. PubMed ID: 25801166
[TBL] [Abstract][Full Text] [Related]
6. Cell type-specific role of CBX2 and its disordered region in spermatogenesis.
Kim JJ; Steinson ER; Lau MS; de Rooij DG; Page DC; Kingston RE
Genes Dev; 2023 Jul; 37(13-14):640-660. PubMed ID: 37553262
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the chromodomain changes the binding specificity of Cbx2 for methylated histone H3.
Hatano A; Matsumoto M; Higashinakagawa T; Nakayama KI
Biochem Biophys Res Commun; 2010 Jun; 397(1):93-9. PubMed ID: 20493168
[TBL] [Abstract][Full Text] [Related]
8. CBX2 is required to stabilize the testis pathway by repressing Wnt signaling.
Garcia-Moreno SA; Lin YT; Futtner CR; Salamone IM; Capel B; Maatouk DM
PLoS Genet; 2019 May; 15(5):e1007895. PubMed ID: 31116734
[TBL] [Abstract][Full Text] [Related]
9. Novel chromobox 2 inhibitory peptide decreases tumor progression.
Brubaker LW; Backos DS; Nguyen VT; Reigan P; Yamamoto TM; Woodruff ER; Iwanaga R; Wempe MF; Kumar V; Persenaire C; Watson ZL; Bitler BG
Expert Opin Ther Targets; 2023; 27(4-5):361-371. PubMed ID: 37243607
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming CBX8-PRC1 function with a positive allosteric modulator.
Suh JL; Bsteh D; Hart B; Si Y; Weaver TM; Pribitzer C; Lau R; Soni S; Ogana H; Rectenwald JM; Norris JL; Cholensky SH; Sagum C; Umana JD; Li D; Hardy B; Bedford MT; Mumenthaler SM; Lenz HJ; Kim YM; Wang GG; Pearce KH; James LI; Kireev DB; Musselman CA; Frye SV; Bell O
Cell Chem Biol; 2022 Apr; 29(4):555-571.e11. PubMed ID: 34715055
[TBL] [Abstract][Full Text] [Related]
11. Live-cell single-molecule tracking reveals co-recognition of H3K27me3 and DNA targets polycomb Cbx7-PRC1 to chromatin.
Zhen CY; Tatavosian R; Huynh TN; Duc HN; Das R; Kokotovic M; Grimm JB; Lavis LD; Lee J; Mejia FJ; Li Y; Yao T; Ren X
Elife; 2016 Oct; 5():. PubMed ID: 27723458
[TBL] [Abstract][Full Text] [Related]
12. A human Polycomb isoform lacking the Pc box does not participate to PRC1 complexes but forms protein assemblies and represses transcription.
Völkel P; Le Faou P; Vandamme J; Pira D; Angrand PO
Epigenetics; 2012 May; 7(5):482-91. PubMed ID: 22419124
[TBL] [Abstract][Full Text] [Related]
13. Cbx2 stably associates with mitotic chromosomes via a PRC2- or PRC1-independent mechanism and is needed for recruiting PRC1 complex to mitotic chromosomes.
Zhen CY; Duc HN; Kokotovic M; Phiel CJ; Ren X
Mol Biol Cell; 2014 Nov; 25(23):3726-39. PubMed ID: 25232004
[TBL] [Abstract][Full Text] [Related]
14. Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer.
Clermont PL; Crea F; Chiang YT; Lin D; Zhang A; Wang JZ; Parolia A; Wu R; Xue H; Wang Y; Ding J; Thu KL; Lam WL; Shah SP; Collins CC; Wang Y; Helgason CD
Clin Epigenetics; 2016; 8():16. PubMed ID: 26877821
[TBL] [Abstract][Full Text] [Related]
15. CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway.
Del Gaudio N; Di Costanzo A; Liu NQ; Conte L; Dell'Aversana C; Bove G; Benedetti R; Montella L; Ciardiello F; Carafa V; Ambrosino C; Tucci V; Conte M; Martens JHA; Stunnenberg HG; Nebbioso A; Altucci L
Mol Cancer; 2022 Jun; 21(1):125. PubMed ID: 35681235
[TBL] [Abstract][Full Text] [Related]
16. Different polycomb group CBX family proteins associate with distinct regions of chromatin using nonhomologous protein sequences.
Vincenz C; Kerppola TK
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16572-7. PubMed ID: 18927235
[TBL] [Abstract][Full Text] [Related]
17. Phase separation of Polycomb-repressive complex 1 is governed by a charged disordered region of CBX2.
Plys AJ; Davis CP; Kim J; Rizki G; Keenen MM; Marr SK; Kingston RE
Genes Dev; 2019 Jul; 33(13-14):799-813. PubMed ID: 31171700
[TBL] [Abstract][Full Text] [Related]
18. Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development.
van Wijnen AJ; Bagheri L; Badreldin AA; Larson AN; Dudakovic A; Thaler R; Paradise CR; Wu Z
Bone; 2021 Feb; 143():115659. PubMed ID: 32979540
[TBL] [Abstract][Full Text] [Related]
19. Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal M; Lebeau B; Witcher M
Expert Opin Ther Targets; 2019 Jul; 23(7):565-578. PubMed ID: 31177918
[No Abstract] [Full Text] [Related]
20. SUMOylated PRC1 controls histone H3.3 deposition and genome integrity of embryonic heterochromatin.
Liu Z; Tardat M; Gill ME; Royo H; Thierry R; Ozonov EA; Peters AH
EMBO J; 2020 Jul; 39(13):e103697. PubMed ID: 32395866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
